Research Article | DOI: https://doi.org/10.31579/2693-4779/330
1Ariel University, Adelson School of Medicine, Laniado Hospital, Israel.
2Department of Physics & Astronomy, University College London, Gower Street, London, WC1E 6BT, UK.
*Corresponding Author: Ofer Lahav, Department of Physics & Astronomy, University College London, Gower Street, London, WC1E 6BT, UK.
Citation: Arnon Blum, Constantina Nicolaou, Ben Henghes, Ofer Lahav, (2026), On the Anti-Correlation Between COVID-19 Infection rate and Natural Ultra Violet Index, Clinical Research and Clinical Trials, 15(5); DOI:10.31579/2693-4779/330
Copyright: © 2026, Ofer Lahav. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 16 June 2026 | Accepted: 02 July 2026 | Published: 13 July 2026
Keywords: COVID-19; inflammatory cytokine storms; immunity; biological mechanisms; l-arginine
Background: Although social distancing and public health interventions are known to reduce the transmission of COVID-19, environmental factors may also influence infection rates. We investigated the hypothesis that natural ultraviolet (UV) radiation decreases COVID-19 infections by enhancing host immunity through increased vitamin D synthesis and nitric oxide production, as well as by exerting direct antiviral effects.
Methods: Daily COVID-19 infection data and ultraviolet index (UVI) measurements were analyzed for the United Kingdom from 23 March 2020 to 10 March 2021. The relationship between COVID-19 infections (F) and UVI was assessed using logarithmic transformation, and the correlation between log₁₀(F) and log₁₀(UVI) was calculated, with particular emphasis on the period following the first national lockdown (11 May 2020 to 10 March 2021).
Results: A strong inverse association was observed between COVID-19 infection rates and UVI. During the post-lockdown period, log₁₀(F) and log₁₀(UVI) demonstrated a marked anti-correlation, with a correlation coefficient of −0.934, indicating that higher ambient UV exposure was associated with lower reported infection rates.
Conclusions: The strong inverse correlation between ambient UV radiation and COVID-19 infection rates suggests that environmental UV exposure may contribute to reducing viral transmission. Although this relationship does not establish causality and may reflect the influence of additional confounding factors associated with UVI, the findings support the inclusion of UVI as a variable in epidemiological models of COVID-19 infection and mortality. Further studies in additional countries and geographical regions are warranted to determine the generalizability of these observations and to clarify the underlying biological mechanisms.
Our hypothesis is that natural UV light suppresses the spread of the COVID-19 virus in at least two ways: by affecting the virus itself and by affecting human skin. We note that although natural UV radiation may cause skin cancer, it also generates vitamin D, which supports the immune system. There are three types of solar UV radiation, classified according to their wavelength. UVC is short-wavelength radiation (100–280 nm) and is the most damaging to the human body.
However, it is completely filtered by the atmosphere and does not reach the Earth's surface. It is well known that laboratory-produced UVC is used to inactivate viruses. UVB is medium wavelength radiation (280–315 nm), and most of it is filtered by the atmosphere. UVA is long wave length radiation (315–400 nm) and accounts for approximately 95% of the UV radiation reaching the Earth's surface. The UV Index (UVI) is a measure of the intensity of sun burn producing UV radiation at a particular place and time. Typical UVI values in the UK range from 0 to 8.
The possible correlation between UV light and COVID-19 has been discussed in the literature, with conflicting conclusions. One study [1] found no association between COVID-19 transmission and UV radiation in Chinese cities. Another study [2] reported only a modest impact of UV light and other environmental factors on reducing COVID-19 transmission. A further study [3] suggested that UV radiation may be less effective in areas with high levels of air pollution, where UV light is converted into heat. In contrast, several other studies [4–6] have reported that UV light is associated with a reduced COVID-19 growth rate. Given these conflicting findings regarding the impact of UV light on COVID-19 transmission, we take a fresh look at data from the UK. Our study was also motivated by the second wave of COVID-19 observed in many countries in the Northern Hemisphere during the winter.
Most respiratory viral infections exhibit a seasonal pattern that may be related to climatic changes, humidity, solar UV irradiation, latitude, air pollution, altitude, and human factors, including genetic, epigenetic, and behavioral characteristics. Enveloped viruses, such as influenza A and B, generally exhibit greater stability at lower temperatures [7].
One study examined the climate of 50 cities affected by COVID-19 and found that eight cities had particularly high morbidity and mortality rates. All eight cities were located between latitudes 30°N and 50°N, with average temperatures ranging from 5°C to 11°C and low humidity. Countries located below latitude 35°N had lower COVID-19 mortality rates. In contrast, countries located above 35°N receive insufficient sunlight for adequate vitamin D synthesis. Vitamin D deficiency has been associated with hypertension, diabetes mellitus, obesity, and increased mortality rates [8–11].
Countries with the highest COVID-19 mortality rates are also known to have a high prevalence of vitamin D deficiency, including Italy, Spain, the UK, and France. In contrast, in Nordic countries, where sunlight exposure is limited, vitamin D food fortification is mandatory, and COVID-19 mortality rates were lower during the recent pandemic [12]. Milan is located at latitude 45°N, whereas Naples is located at latitude 40°N. Naples receives approximately 58 more sunny days per year than Milan [13]. During the study period, the COVID-19 death toll was 403 per million in Naples compared with 15,729 per million in Milan, representing more than a 39-fold difference. A study conducted in Scotland found that UVA exposure was inversely associated with the incidence of myocardial infarction, independent of temperature and UVB irradiation [14]. UVA penetrates the epidermis, reaching blood vessels, keratinocytes, and endothelial cells [15].
Sunlight activates nitric oxide (NO) in the skin. Nitric oxide is a potent modulator of the cardiovascular system, reducing blood pressure and peripheral vascular resistance [16–18]. It is also an important signaling molecule involved in maintaining vascular homeostasis, regulating cellular proliferation and inflammatory processes, and exerting antibacterial and antiviral effects [19–21]. Under normal physiological conditions, NO is produced in endothelial cells through the oxidation of L-arginine to nitric oxide and citrulline. However, inducible nitric oxide synthase (iNOS) is calcium-independent and is activated during conditions of acute or chronic inflammation and infection [22–25]. Nitric oxide has been shown to inhibit SARS-CoV replication by interfering with fusion between the viral spike (S) protein and its receptor, angiotensin converting enzyme, and by inhibiting viral RNA replication [26]. Vitamin D stimulates the production of nitric oxide (NO) in the vascular endothelium, which helps prevent severe COVID-19 by protecting blood vessels, blocking viral replication through cellular autophagy, and suppressing dangerous inflammatory cytokine storms [27].
UVA penetrates the dermal layer, reaching keratinocytes, fibroblasts, microvascular endothelial cells, keratinocytes, Langerhans cells, dermal fibroblasts, and melanocytes- all have the capacity to express inducible nitric oxide synthase (iNOS) following activation by cytokines [27, 28, 29].
The data used in this study are publicly available. COVID-19 data were obtained from the Johns Hopkins University (JHU) COVID-19 database, and ultraviolet index (UVI) data were obtained from TEMIS. The data was free for the public and we didn’t need to recruit patients or humans to explore our questions.
Institutional Review Board Statement: the study is on public free data, and there was no need for an Institutional Review Board. The study was on published data free for all, and did not recruit patients or any subjects.
Informed Consent Statement: there was no need for an informed consent in a study that is based on historical data, published free on line, so that researchers could use to their analysis.
In our study, we focused on the UK, using COVID-19 data [29] and UVI data for London [30]. Although the UVI data were obtained for London, the variation in UVI across different locations in the UK is within 0.8 UVI units. The stringency index represents the lockdown measures implemented in the UK and is defined in [31].
Figure 1 shows the daily numbers of infections and deaths in the UK, together with the UVI and stringency index, for the period from 22 January 2020 to 10 March 2021. Visual inspection of the data reveals a strong anti-correlation between daily infections and the UVI.
As expected, the UVI increased from January 2020 to July 2020, when it reached its peak, and then declined. From January to April 2020, while the UVI was increasing, the number of infections also increased. The UK government imposed its first national lockdown on 23 March 2020, resulting in a decrease in infections due to social distancing measures. The lockdown was relaxed on 11 May 2020. However, the increase in the UVI between 23 March and 1 July 2020 may also have contributed to the decline in the number of infections. From 2 July to October 2020, the increase in infections was strongly anti-correlated with the UVI, as quantified in Table 1 and illustrated in Figure 1. In November 2020, the number of cases declined following the implementation of a second national lockdown but increased again after the restrictions were lifted. During this period, the UVI remained low and therefore may not have contributed to reducing the number of cases.
To quantify the correlation observed in Figure 1, we calculated the correlation coefficient between X and Y, as defined in Eq. (1), where μ represents the mean and σ the standard deviation. We applied this analysis to X = log₁₀(UVI) and Y = log₁₀(F). For the period from 23 March 2020 (the date on which the first UK lockdown was imposed) to 10 March 2021, the correlation coefficient was ρ = −0.917, with a p-value of 1.80 × 10⁻¹⁴, indicating a strong inverse correlation and providing strong evidence against the null hypothesis of no correlation. In addition, for the period from 11 May 2020 (when the initial relaxation of lockdown measures began) to 10 March 2021, the correlation coefficient was ρ = −0.934, with a p-value of 2.24 × 10⁻¹³⁶. During this period, the stringency index remained relatively stable, varying by approximately 13%; therefore, the effect of changes in lockdown measures was likely to be limited.
The correlation coefficients (ρ) for different time intervals and time lags of 7 and 14 days are presented in Table 1. Applying a time lag produced only minor changes in the correlation coefficient, probably because multiple competing effects obscured any specific lag effect. Figure 2 shows the daily numbers of infections and the UVI in the upper panel, while the lower panel presents the rolling correlation coefficient between log₁₀(UVI) and log₁₀(F) using a 50-day moving window. A negative correlation between COVID-19 infections and the UVI is evident from mid-April onwards.
| Study period | No lag | 7-day lag | 14-day lag |
| 23 Mar 2020 – 10 Mar 2021 | −0.917 | −0.910 | −0.886 |
| 11 May 2020 – 10 Mar 2021 | −0.934 | −0.922 | −0.896 |
| 2 Jul 2020 – 10 Mar 2021 | −0.927 | −0.910 | −0.879 |
| 28 Oct 2020 – 10 Mar 2021 | −0.751 | −0.738 | −0.611 |
Table 1: Pearson correlation coefficients (ρ) between log₁₀(UVI) and log₁₀(F) for different study periods and time lags. The selected study periods correspond to key phases of the COVID-19 pandemic in the UK: the first national lockdown (23 March–11 May 2020), the subsequent relaxation of restrictions, the period following the minimum number of reported infections (approximately 1 July 2020), and the onset of the second national lockdown after 28 October 2020. Bootstrap analysis showed that the standard error of all correlation coefficients was < 0>
Figure 1: Daily confirmed COVID-19 infections (dark blue) and deaths (light blue) in the United Kingdom, together with the Oxford COVID-19 Government Response Stringency Index (orange) and the ultraviolet index (UVI; red), from 22 January 2020 to 10 March 2021. The figure illustrates the temporal relationship between the progression of the COVID-19 epidemic, seasonal variation in UVI, and the implementation of government restrictions. A marked inverse relationship between COVID-19 infection rates and UVI is apparent following the relaxation of the first national lockdown in May 2020.
In conclusion, we found an intriguing empirical anti-correlation between the daily UVI and COVID-19 infections in the UK, with a correlation coefficient of ρ = −0.934 between 11 May 2020 and 10 March 2021. We are currently extending our analysis to other countries and regions. At present, we highlight the example of Chile as a Southern Hemisphere case. During the periods of increasing (25 March to 6 June 2020) and decreasing (7 June to 28 October 2020) infection rates, we found anti-correlations of ρ = −0.907 and ρ = −0.730, respectively, consistent with the anti-correlation observed in the UK. Another important comparison would be between countries with similar environmental conditions but different lockdown policies, such as Norway and Sweden.
We emphasize that a correlation between two variables does not necessarily imply causation. If UV light directly influences infection rates, it may do so by reducing viral survival, enhancing the immune response through increased vitamin D production, or through a combination of both mechanisms. Alternatively, the UVI may serve as a surrogate marker for other factors. For example, low UVI values may reflect increased time spent indoors (e.g., at home or in shops), thereby increasing opportunities for viral transmission, or may coincide with other winter-related illnesses that increase susceptibility to infection. Additional factors that may contribute include population density, temperature, humidity, air pollution, and other geographical or environmental variables.
We emphasize that COVID-19 transmission is influenced by multiple factors. There is strong empirical evidence that social distancing and mask wearing are important measures for reducing viral transmission. It is also clear that vaccination represents the most effective strategy for controlling COVID-19. Nevertheless, we advocate including UV exposure as a parameter in models of COVID-19 transmission and considering its potential role in future public health and medical strategies.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,